We are live on ! Find out more
GCVRZ

Sanofi Contingent Value Rights
GCVRZ

Delisted

GCVRZ was delisted on the 3rd of March, 2020.

Back to rankings

124 hedge funds and large institutions have $57.3M invested in Sanofi Contingent Value Rights in 2014 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 11 increasing their positions, 27 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

65% more capital invested

Capital invested by funds: $34.8M → $57.3M (+$22.5M)

0% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 7

1% less funds holding

Funds holding: 125 → 124 (-1)

59% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 27

Holders
124
Holders Change
-1
Holders Change %
-0.8%
% of All Funds
3.56%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
11
Reduced
27
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
WA
Whitebox Advisors
Minnesota
+$3.46M
2
Allianz Asset Management
Allianz Asset Management
Germany
+$1.02M
3
CPM
Chesapeake Partners Management
Maryland
+$1.01M
4
GCM
Gruss Capital Management
New York
+$447K
5
CCA
Catalyst Capital Advisors
New York
+$75.8K

Top Sellers

Rank Fund Capital Flow
1
PWAM
Park West Asset Management
California
-$1.65M
2
Millennium Management
Millennium Management
New York
-$632K
3
SAM
Serengeti Asset Management
New York
-$543K
4
SAM
Silverback Asset Management
North Carolina
-$318K
5
OAM
Oxford Asset Management
United Kingdom
-$306K
Name Holding Trade Value Shares
Change 		Change in
Stake
JGC
26
J. Goldman & Co
New York
$200K – – –
TA
27
Teton Advisors
New York
$200K – – –
ACP
28
Andalusian Capital Partners
Connecticut
$179K – – –
Hudson Bay Capital Management
29
Hudson Bay Capital Management
Connecticut
$165K -$159K -329,400 Closed
GCIA
30
Gabelli & Co Investment Advisers
New York
$157K +$14.5K +30,000 +11%
Capstone Investment Advisors
31
Capstone Investment Advisors
New York
$150K – – –
DAM
32
Deltec Asset Management
New York
$150K – – –
BCM
33
Basso Capital Management
Connecticut
$138K – – –
CCA
34
Catalyst Capital Advisors
New York
$116K +$75.8K +156,800 +209%
First Eagle Investment Management
35
First Eagle Investment Management
New York
$113K -$1.45K -3,000 -1%
Goldman Sachs
36
Goldman Sachs
New York
$106K +$9.22K +19,064 +10%
CCP
37
Cyrus Capital Partners
New York
$100K – – –
FRM
38
Fore Research & Management
New York
$96K -$24.2K -50,000 -21%
RFC
39
Russell Frank Company
Washington
$94K – – –
YCM
40
Yakira Capital Management
Connecticut
$82K – – –
U
41
UBS
Switzerland
$51K -$7.93K -16,392 -14%
ZIG
42
Zuckerman Investment Group
Illinois
$51K -$1.16K -2,400 -2%
EEG
43
E.E. Geduld
$50K – – –
PP
44
Paloma Partners
Connecticut
$50K – – –
Wells Fargo
45
Wells Fargo
California
$47K -$492 -1,017 -1%
OCM
46
Osterweis Capital Management
California
$44K -$40.6K -84,000 -49%
CAS
47
CTC Alternative Strategies
Illinois
$37.9K – – –
KAM
48
Knightsbridge Asset Management
California
$37K – – –
IRF
49
IBM Retirement Fund
New York
$35K – – –
Morgan Stanley
50
Morgan Stanley
New York
$30K -$57.6K -119,167 -67%
1
2
3 4 5

GCVRZ Hedge Fund Activity: Q2 2014 in Review

124 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Sanofi Contingent Value Rights (GCVRZ) for Q2 2014, worth a combined $57.3M — up 65% from $34.8M a quarter earlier.

Fund positioning in GCVRZ was balanced in Q2 2014: 7 funds opened new positions, 7 closed out, 11 added to existing stakes and 27 trimmed.

The largest buyer was Whitebox Advisors, adding an estimated $3.46M. The largest seller was Park West Asset Management, exiting entirely with an estimated $1.65M sold.

  • 124 institutional investors held Sanofi Contingent Value Rights (GCVRZ) as of Q2 2014, down from 125 in Q1 2014.
  • Funds reported $57.3M of Sanofi Contingent Value Rights stock for Q2 2014, up 65% quarter-over-quarter.
  • 7 funds opened new Sanofi Contingent Value Rights positions in Q2 2014 and 7 closed out, a net change of 0 holders.
  • The largest Sanofi Contingent Value Rights buyer in Q2 2014 was Whitebox Advisors, an estimated $3.46M added.
  • The largest Sanofi Contingent Value Rights seller in Q2 2014 was Park West Asset Management, an estimated $1.65M sold.

Based on aggregated 13F filings for Q2 2014.